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A type D-related retrovirus has been demonstrated in enzootic nasal tumors (ENTs) of sheep and goats. This
retrovirus, ENT virus (ENTV), has antigenic cross-reactivity with the jaagsiekte sheep retrovirus (JSRV),
which is associated with a contagious lung tumor of sheep (sheep pulmonary adenomatosis). Here, we present
the first report of nucleic acid sequence from ENTV which confirms, at the nucleic acid level, that this
retrovirus is related to JSRV yet apparently distinct from it. Reverse transcription-PCR followed by restriction
enzyme digestion specifically identified ENTV. By this technique, ENTV was demonstrated exclusively in tumor
tissues and exudates of animals with ENT. Thus, there is a unique and consistent association between ENT and
the retrovirus, just as there is between JSRV and sheep pulmonary adenomatosis. This gives further weight to
the hypothesis that these retroviruses are the etiologic agents of the tumors.
Enzootic intranasal tumors (ENTs) of sheep and goats are
contagious adenocarcinomas which can also be transmitted
experimentally (3, 6). ENTs have similarities with another con-
tagious tumor of secretory epithelial cells, known as sheep
pulmonary adenomatosis (SPA, or jaagsiekte ovine pulmonary
carcinoma). Both tumors are associated with retroviruses
which cannot be propagated in vitro. Although no studies have
previously been reported to determine whether ENT and SPA
are different manifestations of disease caused by the same
agent, studies of ENT cases have not found any tumors in the
lungs (7, 19), nor have nasal tumors in SPA-affected animals
been reported.
In the case of SPA, an association with a type B/D retrovirus,
known as jaagsiekte sheep retrovirus (JSRV), is well estab-
lished (15, 17), and the complete nucleotide sequence of the
retrovirus has been determined (22). Recent reports have dem-
onstrated that JSRV is related to sheep endogenous retrovi-
ruses (SERVs), of which there are 10 to 15 copies in the sheep
genome (1, 12, 15). However, reverse transcription-PCR (RT-
PCR)-based techniques, which differentiate JSRV from
SERVs, showed that JSRV is a distinct exogenous virus that is
associated exclusively with SPA tumors (15).
Although studies are at a less advanced stage than for SPA
and JSRV, current evidence points to the association of a type
D-like retrovirus, ENT virus (ENTV), with ENT. The presence
of retrovirus-like particles in ENT of sheep (14, 21) and goats
(7, 19) has been demonstrated by electron microscopy. The
detection of RT activity in fractions from isopycnic gradients
has shown that the retrovirus found in nasal fluid of ENT-
affected goats has the same buoyant density as JSRV (9). In
addition, antigenic cross-reactivity with Mason-Pfizer monkey
virus p27 (8) and recombinant JSRV capsid protein (unpub-
lished observation) indicates that ENTV has a type D retrovi-
ral capsid.
The aim of our studies was to develop a PCR-based detec-
tion technique for ENTV, to confirm its association with ENT,
and to determine the relationship between ENTV and JSRV.
MATERIALS AND METHODS
Source of material. Nasal fluids from four sheep and two goats with naturally
occurring ENT were collected, clarified, and concentrated as described previ-
ously (8). The resultant pellets were resuspended as a 100-fold concentrate in
TNE buffer (0.01 M Tris-Cl [pH 7.5], 0.1 M NaCl, 0.001 M EDTA). Samples of
ENT and of kidney tissues from the same animals were collected at necropsy and
snap frozen in liquid nitrogen. The ENTs were all low-grade adenocarcinomas,
which were locally invasive but not metastatic, and were from 3- to 4-year-old
animals. Lung fluids from SPA-affected animals were collected as described
previously (18). All samples were stored at2708C. The ENT-affected sheep were
verified to be negative for SPA by macroscopic and microscopic pathology at
necropsy. The ENT-affected and SPA-affected cases used in this study were from
the same region of Spain. The negative-control animals were from the United
Kingdom, where ENT has never been reported.
Density gradient fractionation. Pellets from nasal fluids of four sheep and two
goats were analyzed by isopycnic centrifugation on 20 to 55% (wt/wt) sucrose
gradients (13). Fractions (0.5 ml) were collected, and those with densities be-
tween 1.17 and 1.19 g/ml (i.e., those fractions shown to contain peak RT activity
[9]) were pooled, diluted in TNE buffer, and centrifuged at 100,000 3 g for 1 h
at 48C. The pellet was resuspended in 0.5 ml of solution D (4 M guanidinium
thiocyanate, 25 mM sodium citrate [pH 7.0], 0.5% sarcosyl [wt/vol], 0.1 M
2-mercaptoethanol) for RNA preparation.
RNA preparation and RT. Total RNA was extracted from pooled sucrose
gradient fractions, from 100 ml of concentrated nasal fluid, from 100 ml of SPA
lung fluid, or from 0.2 to 0.5 g of tissue by the acid guanidinium thiocyanate-
phenol-chloroform method (2). cDNA was synthesized by random-primed RT as
described previously (15).
gag PCR. The primers and conditions used for PCR of cDNA or of genomic
DNA were exactly as described previously (15): P1 (sense), 59-GCTGCTTTRA
GACCTTATCGAAA-39; and P2 (antisense), 59-ATACTGCAGCYCGATGGC
CAG-39). PCR products were detected by electrophoresis through a 2% agarose
gel in 13 Tris-borate-EDTA buffer in the presence of 0.5 mg of ethidium
bromide per ml.
Cloning of ENTV gag fragments. cDNA from nasal fluid from each of three
ovine ENT cases was amplified by using primers P1 and P2. The products of four
independent PCRs for each animal were pooled, gel purified, and cloned into
pGEMT (Promega) according to the manufacturer’s protocol. Several clones
selected from each ENT case were sequenced on both strands by using the T7
sequencing kit (Pharmacia), with universal and reverse sequencing primers
(Pharmacia), as recommended by the manufacturer. The sequences obtained
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were aligned by using the Genetics Computer Group “pileup” program (11). The
phylogenetic tree was constructed by using the DNAML program from version
4.0 of the PHYLIP package (10).
Restriction endonuclease digestion of RT-PCR products. A 3-ml volume of
103 restriction buffer (Boehringer) and 1 ml (10 U) of restriction endonuclease
(Boehringer) were added to 26 ml of PCR product, and the mixture was incu-
bated at 378C overnight. Digestion products were detected by electrophoresis
through a 2% agarose gel in 13 Tris-borate-EDTA buffer in the presence of 0.5
mg of ethidium bromide per ml.
DNA extraction. High-molecular-weight genomic DNA was extracted from
nasal tumor and kidney samples of the same naturally affected animals or from
lung and kidney samples of unaffected controls by cell lysis followed by precip-
itation of DNA in tissue culture plates, as described by Wu et al. (20).
Nucleotide sequence accession numbers. The nucleotide sequence of one of
the ENTV gag fragment PCR clones, pENTV7.6, is deposited in GenBank under
accession no. Z71758.
RESULTS
Development of a technique for specific detection of ENTV.
Primers P1 and P2, which amplify a 229-bp region internal to
the gag gene of JSRV and of SERVs (15), amplified products
of the same size from cDNAs derived from clarified nasal
fluids of four sheep and two goats affected by ENT and from
density gradient-purified virus from the same sources. The gag
RT-PCR product from JSRV isolates cut with ScaI, while that
from SERVs or ENTV did not (data not shown). To look for
an alternative restriction site by which to distinguish ENTV
from SERVs, gag RT-PCR products of three ovine ENT cases,
from different farms, were cloned and sequenced. Alignment
of the sequences (Fig. 1) with the published sequences of
JSRV and SERVs showed a number of bases at which there
appear to be conserved differences between ENTV and JSRV
or SERV. Of particular interest were the presence of a PstI site
(positions 75 to 80) and an AatII site (positions 141 to 146)
unique to the ENTV gag sequences and the lack of the ScaI
site (positions 106 to 111) which has been shown to be present
in all JSRV isolates tested to date (15).
Association of ENTV with ENT. To confirm the association
of the virus with ENT and the conservation of the AatII and
PstI restriction sites, gag RT-PCR was done with 26 different
samples (typical results are shown in Fig. 2). The product from
nontumor (kidney) tissues of four of the ENT-affected animals
or of four unaffected controls did not cut, as was expected for
endogenously derived amplimers. The product from JSRV, in
lung fluid or tumor samples from SPA-affected sheep, also did
not cut with AatII or PstI. However, the RT-PCR gag products
FIG. 1. Alignment of the sequences of RT-PCR gag products from ovine ENTV with SERV sequences (15) and JSRV sequences from South Africa [JSRV(SA)]
(22) and the United States [JSRV(US)] (12). Only the sequence between the PCR primers is shown. Base differences in comparison with the ENTV consensus (letters)
and restriction sites specific to ENTV or JSRV (boldface) are shown.
FIG. 2. Detection of ENTV transcripts. gag RT-PCR products after incuba-
tion with PstI (a) or AatII (b) are shown. Lanes 1, 2, 4, and 5, nasal fluids from
ENT-affected sheep; lanes 6, 8, 9, and 10, tumor tissues from ENT-affected
animals; lanes 5 to 7, nasal fluid, tumor, and kidney samples, respectively, from
the same ENT-affected sheep; lanes 3, 11, and 12, lung fluid, tumor, and kidney
specimens, respectively, from the same SPA-affected animal; lane 13, negative
control; lane 14, pJS382 (JSRV gag clone); lane M, Boehringer marker VI.
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from six ENT nasal fluid specimens (from four sheep and two
goats) and six ENT tissue specimens (from four sheep and two
goats) cut with both enzymes, demonstrating the presence of
exogenous ENTV. Amplimers from isopycnic gradient-puri-
fied fractions were expected to cut completely, as they should
contain no endogenous sequences. However, restriction en-
zyme digestion was incomplete. The efficiency of the restriction
enzymes was checked by digestion of PCR product amplified
from plasmid pENTV7.6 (sequence shown in Fig. 1) and was
found to be less than expected. Nevertheless, the results show
that AatII- and PstI-sensitive product was detectable in all
tumor and fluid samples from animals with ENT.
DNAs from tumor and kidney tissues of two sheep and two
goats affected by ENT were used as templates for gag PCR
followed by PstI or AatII digestion to determine whether these
restriction sites were present in any of the related endogenous
sequences. No AatII- or PstI-sensitive product was detected
(results not shown).
Relationship between ENTV, JSRV, and SERVs. Compari-
son of the 10 ENTV sequences with the published sequences of
JSRV and SERVs showed that the ENTV sequences were 95
to 100% similar to each other, 83 to 92% similar to JSRV
sequences, and 83 to 92% similar to SERV sequences. Figure
3 shows a phylogenetic tree constructed from the gag se-
quences. The long branch linking the ENTV sequence cluster
to the rest (SERV and JSRV) was significantly greater than 0
(length, 0.09676 nucleotide substitutions per position, i.e.,
about 10% sequence divergence or 22 nucleotide substitutions
in 229 bp). The ordering of the gag fragments within the ENTV
cluster and within the SERV-JSRV cluster was not significant.
The optimum Ts/Tv value was 7.0, suggesting that transitions
are much more common than transversions (e.g., A3G is 14
times more likely than A3T). The relative rates at the three
codon positions were 1:1:10, confirming that the first two
codon positions are constrained relative to the third position
(which is likely to be evolving at close to the neutral rate) and
suggesting that the part of the CA protein encoded by this
region of gag does not evolve rapidly.
DISCUSSION
We have previously reported that the presence of a ScaI
restriction site within gag is a molecular marker for JSRV (15).
Here, we report that the restriction sites AatII and PstI within
gag act as unique molecular markers for ENTV. gag RT-PCR
analysis of samples from clinical ENT cases and from unaf-
fected controls demonstrated that the virus transcripts distin-
guished by the AatII and PstI restriction sites were present
exclusively and consistently in tumor tissues and exudates from
ENT cases. ENTV therefore appears to be a distinct virus
associated with ENT. By analogy with JSRV, ENTV is likely to
be an exogenous virus as opposed to a reactivated endogenous
virus. Our findings that no endogenously derived sequences
containing AatII or PstI were detected at either the RNA or
the DNA level support this notion but because of the limita-
tions of sensitivity of the present technique are not conclusive.
These limitations are highlighted by the fact that we were
unable to demonstrate the presence of ENTV provirus in tu-
mor tissue DNA. This observation agrees with our findings for
JSRV, for which provirus could not be detected in SPA tumor
DNA by using the gag PCR-ScaI technique because of the high
background of endogenous sequences (15). This problem was
overcome by the development of primers specific for exoge-
nous JSRV which enabled detection of proviral DNA in tumor
tissue. These JSRV primers do not amplify ENTV, and further
sequence data for ENTV are necessary in order to design
specific primers and develop a more sensitive PCR for detec-
tion of ENTV.
The fact that the AatII and PstI sites were conserved in
ENTV whereas the ScaI site is conserved in JSRV suggests
that ENTV and JSRV are distinct viruses. This notion is sup-
ported by the phylogenetic tree, which shows that the JSRV
and SERV sequences are more similar to each other than they
are to the ENTV sequences. However, such short regions of
sequence should not be overinterpreted. It is not possible to
extrapolate the conclusion from this small region of sequence
to predict differences in other regions of the viral genomes, as
it is likely that the gag gene may be the region of greatest
homology between the two viruses, especially since analysis of
the sequences suggests that the gag region is not evolving
rapidly. In addition, the CA proteins of JSRV and ENTV,
encoded by gag, are antigenically related (8). However, anti-
genic relatedness of other viral components has not yet been
investigated. PCRs which amplify other regions of JSRV and
of SERVs (long terminal repeat, pol, and env) did not amplify
ENTV (data not shown). Caution should be exercised in in-
terpretation of negative PCR results since minor differences
between two genomes can prevent efficient primer binding;
nevertheless, this result suggests not only that other genes of
ENTV are less similar to those of JSRV and SERVs but also
that ENTV is less similar to SERVs than is JSRV. This agrees
with the phylogenetic tree.
In sheep and goats, ENTs are clinically and pathologically
identical (4, 5), but, until now, there have been no data to
confirm that the same virus affects the two species. Our studies
show that the AatII and PstI sites are present in the gag region
of the viruses from ENT samples of both sheep and goats,
suggesting that the viruses are highly related. Similar intranasal
tumors in other animals including cattle, buffaloes, and pigs
have also been reported (16), and the RT-PCR–restriction
enzyme technique could be used to determine whether these
tumors are also associated with ENTV.
In conclusion, this is the first report of nucleic acid sequence
from ENTV, and it confirms, at the nucleic acid level, that this
retrovirus is related to JSRV yet apparently distinct from it.
FIG. 3. Phylogenetic tree constructed from the sequences shown in Fig. 1.
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ENTV can be specifically identified by RT-PCR followed by
AatII or PstI digestion, and, by this technique, ENTV was
demonstrated exclusively and consistently in nasal tumor tis-
sues and exudates from ENT-affected sheep and goats. The
facts that SPA and ENT are both adenocarcinomas of secre-
tory epithelial cells but target different areas of the respiratory
tract and that JSRV and ENTV are also similar but distinct
add further weight to the hypothesis that these retroviruses are
the etiological agents of the tumors.
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